Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Clinical trial NCT00096018 · COMPLETED
Trial details
- NCT number
- NCT00096018
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.